| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $80.9M | — | +44.8% |
| Cost of Revenue | $63.4M | — | +18.2% |
| Gross Profit | $17.5M | — | +686.5% |
| R&D Expense | $67.5M | — | +40.6% |
| SG&A Expense | $45.6M | — | +257.7% |
| Operating Income | -$95.7M | — | -63.4% |
| Interest Expense | $6.2M | — | +0.0% |
| Pre-tax Income | -$96.6M | — | -60.8% |
| Income Tax | $67K | — | — |
| Net Income | -$96.7M | — | -60.9% |
| EPS (Basic) | -$0.61 | — | +88.7% |
| EPS (Diluted) | -$0.61 | — | +88.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $326.2M | -58.9% | +84.4% |
| Short-term Investments | $225.4M | +125.4% | — |
| Accounts Receivable | $44.8M | -2.9% | — |
| Current Assets | $673.5M | -30.1% | — |
| Total Assets | $1.49B | -18.2% | — |
| Current Liabilities | $266.2M | +24.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$62.5M | — | -10.6% |
| Capital Expenditures | $16.3M | — | +515.9% |
| Investing Cash Flow | -$141.3M | — | -5225.4% |
| Financing Cash Flow | -$262.9M | — | -330.8% |
| Free Cash Flow | -$78.9M | — | -33.3% |
| — |
| Total Liabilities | $387.1M | -39.0% | — |
| Stockholders' Equity | $1.10B | -7.1% | +231.7% |